BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 38629481)

  • 1. Navigating the future of Alzheimer's care in Ireland - a service model for disease-modifying therapies in small and medium-sized healthcare systems.
    Leroi I; Dolphin H; Dinh R; Foley T; Kennelly S; Kinchin I; O'Caoimh R; O'Dowd S; O'Philbin L; O'Reilly S; Trepel D; Timmons S
    BMC Health Serv Res; 2024 Jun; 24(1):705. PubMed ID: 38840115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus report.
    Jicha GA; Abner EL; Arnold SE; Carrillo MC; Dodge HH; Edland SD; Fargo KN; Feldman HH; Goldstein LB; Hendrix J; Peters R; Robillard JM; Schneider LS; Titiner JR; Weber CJ;
    Alzheimers Dement; 2022 Jun; 18(6):1109-1118. PubMed ID: 34590417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donepezil for dementia due to Alzheimer's disease.
    Birks JS; Harvey RJ
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights and recommendations for working collaboratively and improving care in Alzheimer's disease: Learnings from the Finding Alzheimer's Solutions Together (F.A.S.T.) Council.
    Roeser J; Bayliss N; Blom M; Croney R; Lanman L; Laks J; Lyons M; Proulx L; Tsatali M; Westerlund K; Georges J
    Health Expect; 2024 Apr; 27(2):e14040. PubMed ID: 38629481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White paper on expanding the role of pharmacists in caring for individuals with Alzheimer's disease: APhA Foundation Coordinating Council to Improve Collaboration in Supporting Patients with Alzheimer's Disease.
    Skelton JB
    J Am Pharm Assoc (2003); 2008; 48(6):715-21. PubMed ID: 19019799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collaboration between patient organisations and a clinical research sponsor in a rare disease condition: learnings from a community advisory board and best practice for future collaborations.
    Roennow A; Sauvé M; Welling J; Riggs RJ; Kennedy AT; Galetti I; Brown E; Leite C; Gonzalez A; Portales Guiraud AP; Houÿez F; Camp R; Gilbert A; Gahlemann M; Moros L; Luna Flores JL; Schmidt F; Sauter W; Finnern H
    BMJ Open; 2020 Dec; 10(12):e039473. PubMed ID: 33328257
    [No Abstract]   [Full Text] [Related]  

  • 8. Design of comprehensive Alzheimer's disease centers to address unmet national needs.
    Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM
    Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences of stigma and discrimination among people living with dementia and family carers in Brazil: Qualitative study.
    Oliveira D; da Mata F; Mateus E; Musyimi CW; Farina N; Ferri CP; Evans-Lacko S
    Ageing Soc; 2023 Feb; 43(2):447-468. PubMed ID: 37920698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to get serious about the Global Action Plan on dementia.
    The Lancet Neurology
    Lancet Neurol; 2023 Aug; 22(8):643. PubMed ID: 37479361
    [No Abstract]   [Full Text] [Related]  

  • 11. A global view of the genetic basis of Alzheimer disease.
    Reitz C; Pericak-Vance MA; Foroud T; Mayeux R
    Nat Rev Neurol; 2023 May; 19(5):261-277. PubMed ID: 37024647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2019.
    Li X; Feng X; Sun X; Hou N; Han F; Liu Y
    Front Aging Neurosci; 2022; 14():937486. PubMed ID: 36299608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials.
    Langbaum JB; Zissimopoulos J; Au R; Bose N; Edgar CJ; Ehrenberg E; Fillit H; Hill CV; Hughes L; Irizarry M; Kremen S; Lakdawalla D; Lynn N; Malzbender K; Maruyama T; Massett HA; Patel D; Peneva D; Reiman EM; Romero K; Routledge C; Weiner MW; Weninger S; Aisen PS
    Alzheimers Dement; 2023 Feb; 19(2):696-707. PubMed ID: 35946590
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.